Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 24, 2012

View Archived Issues

Researchers from Canada link CX3CR1 to neural degeneration in CSM

JNJ-41477670: a novel TRPA1 antagonist with a promising pharmacokinetic profile

Millennium presents first clinical results for two of its anticancer compounds

Genetic variations shared between obesity and ADHD identified

Durable immune responses seen in vivo with HSV-2 vaccine

Prosensa advances DMD candidates, obtains orphan drug designations

PTC Therapeutics receives NIH funding for dengue research

Biotica Technology discloses new cyclophilin A inhibitors

Amicus achieves target enrollment in phase III migalastat hydrochloride study

Interim 6-month results of 2-year extension STEPS2 trial presented

Novel antibacterial agents patented by Brown University

Lilly reports results from three phase III AWARD trials

Researchers at GE Healthcare divulge new PET imaging agents

AIM Therapeutics commences dosing in phase II AIM-102 trial

Novel TRPV3 channel inhibitors disclosed by Abbott Laboratories

Merck & Co. patents new compounds for cancer

Corcept Therapeutics presents new glucocorticoid receptor antagonists

FDA approves extended-release formulation of oxcarbazepine

Cel-Sci reports interim review results from phase III Multikine study

ISTO Technologies plans phase II NuQu study in discogenic back pain

LabCorp to develop tuberculosis antimicrobial susceptibility test using B-SMART

Minimally invasive non-small cell lung cancer model devised

AnGes and Mitsubishi Tanabe Pharma agree on Collategene U.S. rights

Avanir receives Michael J. Fox Foundation grant to study AVP-923

SARcode Bioscience discloses topline results from phase III lifitegrast study

Cosmo Pharmaceuticals reports data from phase II methylene blue MMX study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...